{
  "ticker": "ABCL",
  "company_name": "AbCellera Biologics Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07118891",
      "title": "Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Vasomotor Symptoms Associated With Menopause, Healthy Volunteers",
      "start_date": "2025-06-23",
      "completion_date": "2027-02",
      "enrollment": 0,
      "sponsor": "AbCellera Biologics Inc."
    },
    {
      "nct_id": "NCT04603651",
      "title": "Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19",
      "status": "NO_LONGER_AVAILABLE",
      "phase": "",
      "condition": "COVID-19",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Eli Lilly and Company"
    },
    {
      "nct_id": "NCT04634409",
      "title": "A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "COVID-19",
      "start_date": "2020-10-29",
      "completion_date": "2021-10-18",
      "enrollment": 0,
      "sponsor": "Eli Lilly and Company"
    },
    {
      "nct_id": "NCT04411628",
      "title": "A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "COVID-19",
      "start_date": "2020-05-28",
      "completion_date": "2020-08-26",
      "enrollment": 0,
      "sponsor": "Eli Lilly and Company"
    },
    {
      "nct_id": "NCT07108894",
      "title": "A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants",
      "status": "RECRUITING",
      "phase": "EARLY_PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2025-07-25",
      "completion_date": "2026-11",
      "enrollment": 0,
      "sponsor": "AbCellera Biologics Inc."
    },
    {
      "nct_id": "NCT04427501",
      "title": "A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness",
      "status": "COMPLETED",
      "phase": "PHASE2, PHASE3",
      "condition": "COVID-19",
      "start_date": "2020-06-17",
      "completion_date": "2023-02-21",
      "enrollment": 0,
      "sponsor": "Eli Lilly and Company"
    },
    {
      "nct_id": "NCT04497987",
      "title": "A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "COVID-19, SARS-CoV2",
      "start_date": "2020-08-02",
      "completion_date": "2021-05-20",
      "enrollment": 0,
      "sponsor": "Eli Lilly and Company"
    },
    {
      "nct_id": "NCT04701658",
      "title": "A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "COVID-19",
      "start_date": "2021-02-01",
      "completion_date": "2021-06-22",
      "enrollment": 0,
      "sponsor": "Eli Lilly and Company"
    }
  ],
  "summary": {
    "total_trials": 8,
    "by_phase": {
      "PHASE1, PHASE2": 1,
      "": 1,
      "PHASE2": 2,
      "PHASE1": 1,
      "EARLY_PHASE1": 1,
      "PHASE2, PHASE3": 1,
      "PHASE3": 1
    },
    "by_status": {
      "RECRUITING": 2,
      "NO_LONGER_AVAILABLE": 1,
      "COMPLETED": 5
    },
    "active_trials": 2,
    "completed_trials": 5,
    "conditions": [
      "COVID-19",
      "COVID-19, SARS-CoV2",
      "Healthy Volunteers",
      "Vasomotor Symptoms Associated With Menopause, Healthy Volunteers"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:15:48.927788",
    "search_query": "AbCellera Biologics Inc.",
    "url": "https://clinicaltrials.gov/search?term=AbCellera+Biologics+Inc."
  }
}